Company
Emmaus Life Sciences, Inc.
EMMA · CIK 0000822370
Purchase of 100,000 shares at $0.05 per share.
Reporting Person LEE WILLIS C · Officer Title CEO · Transaction Code P
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001193125-26-380023 · filed 2026-09-02 · View filing →
Purchase of 94,767 shares at $0.06 per share.
Reporting Person LEE WILLIS C · Officer Title CEO · Transaction Code P
Traded Aug 28, 2026 · Disclosed Sep 2, 2026FILED +5 DAYS
Source: SEC Form 4 · 0001193125-26-380023 · filed 2026-09-02 · View filing →
Purchase of 50,000 shares at $0.05 per share.
Reporting Person LEE WILLIS C · Officer Title CEO · Transaction Code P
Traded Aug 27, 2026 · Disclosed Sep 2, 2026FILED +6 DAYS
Source: SEC Form 4 · 0001193125-26-380023 · filed 2026-09-02 · View filing →
Purchase of 46,000 shares at $0.04 per share.
Reporting Person LEE WILLIS C · Officer Title CEO · Transaction Code P
Traded Aug 25, 2026 · Disclosed Sep 2, 2026FILED +8 DAYS
Source: SEC Form 4 · 0001193125-26-380023 · filed 2026-09-02 · View filing →
Purchase of 170,000 shares at $0.01 per share.
Reporting Person LEE WILLIS C · Officer Title CEO · Transaction Code P
Traded Aug 29, 2025 · Disclosed Sep 2, 2026FILED +369 DAYS
Source: SEC Form 4 · 0001193125-26-380023 · filed 2026-09-02 · View filing →
Purchase of 70,000 shares at $0.02 per share.
Reporting Person LEE WILLIS C · Officer Title CEO · Transaction Code P
Traded May 30, 2025 · Disclosed Sep 2, 2026FILED +460 DAYS
Source: SEC Form 4 · 0001193125-26-380023 · filed 2026-09-02 · View filing →